Literature DB >> 2852125

Concomitant immunity leads to retardation or acceleration of the growth of Rous sarcomas in genetically resistant or susceptible inbred lines of chickens.

J Plachý1, I Karakoz, V Benda.   

Abstract

We report results on the age-dependent effect of the B (MHC) genotype on resistance to the growth of a second RSV tumour in chickens from highly inbred lines genetically resistant or susceptible to progressive growth of primary RSV-induced tumours. Furthermore, the second inoculation of RSV caused either accelerated or retarded growth of the primary tumours induced by the same virus. These two types of response to a second challenge with RSV were controlled by alleles of the chicken major histocompatibility (B) complex. The retarded growth of the primary tumours was found to be thymus-dependent. Furthermore, a clear-cut trans-complementation effect of two B alleles on the response to RSV challenge was demonstrated.

Entities:  

Mesh:

Year:  1986        PMID: 2852125

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  4 in total

1.  Tumor induction by the LTR, v-src, LTR DNA in four B (MHC) congenic lines of chickens.

Authors:  J Svoboda; J Plachý; J Hejnar; I Karakoz; R V Guntaka; J Geryk
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

2.  Suppression of Rous sarcoma virus-induced tumor formation by preinfection with viruses encoding src protein with novel N termini.

Authors:  I H Gelman; H Hanafusa
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

3.  src-specific immunity in inbred chickens bearing v-src DNA- and RSV-induced tumors.

Authors:  J Plachý; K Hála; J Hejnar; J Geryk; J Svoboda
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

4.  Tumor immunity generated in the course of regression of v-src-induced sarcomas.

Authors:  T W Wisner; J M England; D Y Pan; A W Stoker; M S Halpern
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.